Acral lentiginous melanoma: Who benefits from sentinel lymph node biopsy?
Authors:
- 1 January 2015
- journal article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 72 (1) , 71-77
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Center
- Ministry of Education, Culture, Sports, Science and Technology
- Ministry of Health, Labour and Welfare
This publication has 22 references indexed in Scilit:
- A Clinicopathologic Analysis of 177 Acral Melanomas in KoreansJAMA Dermatology, 2013
- Unique prognostic factors in acral lentiginous melanomaThe American Journal of Surgery, 2012
- The prognostic value of a reverse transcriptase-PCR assay of sentinel lymph node biopsy for patients with cutaneous melanomaMelanoma Research, 2012
- Melanoma of the hand and foot: epidemiological, prognostic and genetic features. A systematic reviewBritish Journal of Dermatology, 2011
- Acral Lentiginous MelanomaArchives of Dermatology, 2009
- Importance of Sentinel Lymph Node Biopsy in Patients With Thin MelanomaArchives of Surgery, 2008
- Acral lentiginous melanoma: histopathological prognostic features of 121 casesBritish Journal of Dermatology, 2007
- Acral lentiginous melanoma: a clinicoprognostic study of 126 casesBritish Journal of Dermatology, 2006
- Malignant melanoma in Taiwan: a prognostic study of 181 casesMelanoma Research, 2004
- Technical Details of Intraoperative Lymphatic Mapping for Early Stage MelanomaArchives of Surgery, 1992